Diagnosing Rheumatoid Arthritis
Use the 2010 ACR/EULAR Classification Criteria, which requires a score of ≥6/10 points based on joint involvement, serology, acute phase reactants, and symptom duration to diagnose rheumatoid arthritis. 1
Target Population for Testing
- Apply diagnostic criteria only to patients with at least one joint showing definite clinical synovitis (swelling) that is not better explained by another disease. 1, 2
- Symmetric involvement of small joints—particularly metacarpophalangeal (MCP) joints, proximal interphalangeal (PIP) joints, wrists, and metatarsophalangeal (MTP) joints—is characteristic of RA. 3
- Large joints (shoulders, elbows, hips, knees, ankles) may also be affected, but distal interphalangeal joints, first carpometacarpal joints, and first MTP joints are typically spared. 3
The 2010 ACR/EULAR Scoring System
A score of ≥6/10 points is required for definite RA classification. 1 Calculate the score by adding points from four categories:
A) Joint Involvement (0-5 points)
- 1 large joint = 0 points 1
- 2-10 large joints = 1 point 1
- 1-3 small joints (with or without large joint involvement) = 2 points 1
- 4-10 small joints (with or without large joint involvement) = 3 points 1
10 joints, including at least 1 small joint = 5 points 1
B) Serology (0-3 points)
- Negative RF and negative ACPA = 0 points 1
- Low positive RF or low positive ACPA = 2 points 1
- High positive RF or high positive ACPA = 3 points 1
Critical caveat: Seronegative RA accounts for 20-30% of cases, so negative RF does not exclude RA. 3, 4 Do not delay treatment waiting for positive serology—seronegative RA has a similar prognosis to seropositive disease. 3, 4
C) Acute Phase Reactants (0-1 point)
Use CRP rather than ESR because it is more reliable, simpler, and not age-dependent. 1 However, acute phase reactants can be normal even in active disease, so do not dismiss the diagnosis based on normal inflammatory markers. 3
D) Duration of Symptoms (0-1 point)
Essential Clinical Examination
Perform a 28-joint count assessment examining for tenderness and swelling in: 1, 3
- PIPs (1st through 5th bilaterally)
- MCPs (1st through 5th bilaterally)
- Wrists
- Elbows
- Shoulders
- Knees
Squeeze test of MCPs and MTPs helps assess for clinical synovitis. 3
Look for early-morning stiffness lasting ≥1 hour and difficulty making a fist. 3, 4
Laboratory Workup
Initial Testing
- ACPA (anti-citrullinated protein antibody): High specificity (90%) with moderate sensitivity (60%) 3
- Rheumatoid factor (RF): Lower specificity (70%) with similar sensitivity to ACPA 3
- CRP (preferred over ESR) 1
- Complete blood count with differential 3, 5
- Comprehensive metabolic panel (liver function, renal function, glucose, urate) 3
- Urinalysis 3
Additional Testing When Diagnosis is Uncertain
- ANA to screen for other connective tissue diseases 3
- HLA-B27 if spondyloarthropathy is being considered 3
Pre-Treatment Screening (Before Biologics)
- Hepatitis B, Hepatitis C, and tuberculosis screening are required before starting any biologic therapy. 3, 5
Imaging Studies
Baseline Imaging
Obtain bilateral hand, wrist, and foot X-rays at baseline to detect erosions and monitor structural damage progression. 3, 4
Conventional radiography findings include: 3
- Periarticular osteopenia
- Uniform joint space narrowing
- Osseous erosions
Erosions predict RA diagnosis and disease persistence. 3
Advanced Imaging (When Criteria Not Met)
- Ultrasound is superior to clinical examination for detecting inflammation and structural damage, and can detect synovitis that predicts disease progression. 3
- Power Doppler ultrasound is useful when patients with early arthritis do not meet the 2010 ACR/EULAR criteria. 3
- MRI with IV contrast is more sensitive than ultrasound in early stages, detecting bone marrow edema (osteitis), which is the best single predictor of future disease progression and functional deterioration. 3
Clinical Examples
Example of early RA diagnosis: A patient with early-morning stiffness, a swollen wrist joint, and strongly positive ACPA test results for 6 weeks (or less with an abnormal CRP) fulfills the criteria for RA, and disease-modifying therapy should be initiated. 1
Differential Diagnoses to Exclude
Before diagnosing RA, exclude: 1, 3, 4
- Psoriatic arthritis
- Gout (check uric acid level)
- Hemochromatosis
- Systemic lupus erythematosus
- Spondyloarthropathies
- Crystal arthropathies
- Polymyalgia rheumatica
- Still's disease
Urgent Referral Strategy
Patients with suspected early RA should be seen within 1-2 weeks of referral through "early arthritis clinics" or urgent appointment slots. 1 Early diagnosis allows for earlier treatment with disease-modifying antirheumatic drugs, which is associated with better outcomes. 2, 5
Disease Activity Assessment After Diagnosis
Once RA is diagnosed, quantitative assessment of disease activity is essential using composite measures: 1, 3
- DAS28 (Disease Activity Score using 28 joint counts) 3
- SDAI (Simplified Disease Activity Index): Remission ≤3.3, low disease activity ≤11 3, 4
- CDAI (Clinical Disease Activity Index): Remission ≤2.8, low disease activity ≤10 3
Include patient-reported outcomes: 1
- Pain assessment
- Patient Global Assessment of Disease Activity
- Health Assessment Questionnaire Disability Index
The primary target of treatment is remission or low disease activity. 3, 6